Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Capital Expenditures (2024 - 2025)

Guardian Pharmacy Services' Capital Expenditures history spans 2 years, with the latest figure at $495000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 78.0% year-over-year to $495000.0; the TTM value through Dec 2025 reached $9.0 million, changed N/A, while the annual FY2025 figure was $13.4 million, 8.8% down from the prior year.
  • Capital Expenditures for Q4 2025 was $495000.0 at Guardian Pharmacy Services, down from $4.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.0 million in Q3 2025 and bottomed at $495000.0 in Q4 2025.